Gains for Dr Reddy from his Distribution Partnership with Sanofi Healthcare

Dr. Reddy's Labs' Partnership Boosts

Enhances portfolio and market presence.

Deal includes popular vaccine brands.

Securing exclusive distribution pact with Sanofi Healthcare India.

Dr. Reddy's Acquires Sanofi's India Vaccine Distribution Rights

Benefits healthcare professionals and patients.

Aims to increase vaccine accessibility.

Click Here

Dr. Reddy's Market Position Strengthening

Enhances the competitive pharmaceutical landscape.

Sanofi's vaccine brands were added.

Gains second position among Indian vaccine players.

CEO Ramana's Commitment to Expansion

Signals dedication to healthcare advancement.

Emphasizes Dr. Reddy's innovation.

Aims to serve 1.5 billion patients by 2030.

Company Board to Approve Q4 2024 Financial Results

Reflecting positive market response.

Meeting on May 7, 2024

Open Demat